Tag: Combination therapy
Improved Survival in ES-SCLC with Lurbinectedin/Atezolizumab Combination
A combination of lurbinectedin and atezolizumab has shown significant benefits in overall survival (OS) and progression-free survival (PFS) for patients with extensive-stage small cell...
Limited Benefit of Nivolumab/Tivozanib in Advanced RCC Post-Immunotherapy
The combination of nivolumab and tivozanib did not show an improvement in progression-free survival (PFS) for patients with advanced metastatic renal cell carcinoma (RCC)...